Please activate JavaScript in your browser settings to enable all features of this website.

Möchten Sie zur deutschen Seite wechseln?JaNeina
Close

Disease Atlas

Strengthening your value story from pre-launch to launch and beyond.

What it is
GfK Disease Atlas, our global real-world evidence program, helps uncover unmet needs, identify new opportunities and support successful market access.

How it works
How do you defy the attrition rate for product development and successfully achieve market access? And once launched, how do you influence the performance of your brand? Large-scale, disease-specific GfK Disease Atlas makes it all possible. This evidence-based program is unique in linking real-world clinical practice with insights from the key stakeholders involved across the healthcare continuum –physicians, patients and payers.

Benefits
Since GfK Disease Atlas is global, you can expect a detailed understanding of healthcare practice and patient access across all markets. So you can leverage strategic opportunities, shape your innovation practices, inform market access strategies and deliver patient access and uptake. Think of GfK Disease Atlas as a robust, reliable, publishable source to support your value proposition and give your work plans their strategic edge.

Related Industries
  • Health

    Health

    In the healthcare industry, innovation is judged far more by whether it delivers engaging health experiences than by the level of invention. And market access for state-of-the-art healthcare is under pressure globally.